ALRN - Aileron Therapeutics GAAP EPS of -$0.07 beats by $0.01
- Aileron Therapeutics press release ( NASDAQ: ALRN ): Q3 GAAP EPS of -$0.07 beats by $0.01 .
- Cash, cash equivalents, and investments on September 30, 2022, were $25.5 million, compared to $45.9 million on December 31, 2021.
For further details see:
Aileron Therapeutics GAAP EPS of -$0.07 beats by $0.01